stars 1 stars 2 stars 3

Founded in Switzerland in 2001, Acrostak has been designing, manufacturing, and commercializing innovative medical devices for interventional cardiology. Continuously pushing to be at the forefront of innovation, with a focus on improving patient’s outcomes today, we are committed to developing tomorrow’s next generation medical technology. Over more than 20 years, we have established a global presence and strategic partnerships with leading hospitals and renowned cardiologists. OUR MISSION We are committed to cultivating a creative environment where new ideas evolve into breakthrough solutions that deliver value to our patients, customers, employees, and shareholders alike. OUR VALUES Customer come first Aspire to inspire Respect colleagues Effectively communicate OUR VISION To become a leader in the interventional applications market by developing and delivering innovative, top-quality products designed to enhance patient outcomes.

Acrostak Questions

The Acrostak annual revenue was $4 million in 2026.

Bar Goldfarb is the CTO and R and D Team Lead of Acrostak.

13 people are employed at Acrostak.

Acrostak is based in Geneva, Geneva.

The NAICS codes for Acrostak are [33, 339].

The SIC codes for Acrostak are [384, 38].

Top Acrostak Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users